Shanghai Pharmaceuticals Holding Co., Ltd

SHSE:601607 Voorraadrapport

Marktkapitalisatie: CN¥64.7b

Shanghai Pharmaceuticals Holding Beheer

Beheer criteriumcontroles 2/4

Shanghai Pharmaceuticals Holding's CEO is Bo Shen, appointed in Mar 2010, has a tenure of 14.67 years. total yearly compensation is CN¥5.80M, comprised of 21.5% salary and 78.5% bonuses, including company stock and options. directly owns 0.002% of the company’s shares, worth CN¥1.26M. The average tenure of the management team and the board of directors is 2.3 years and 1.4 years respectively.

Belangrijke informatie

Bo Shen

Algemeen directeur

CN¥5.8m

Totale compensatie

Percentage CEO-salaris21.5%
Dienstverband CEO14.7yrs
Eigendom CEO0.002%
Management gemiddelde ambtstermijn2.3yrs
Gemiddelde ambtstermijn bestuur1.4yrs

Recente managementupdates

Recent updates

Not Many Are Piling Into Shanghai Pharmaceuticals Holding Co., Ltd (SHSE:601607) Just Yet

Sep 30
Not Many Are Piling Into Shanghai Pharmaceuticals Holding Co., Ltd (SHSE:601607) Just Yet

Shanghai Pharmaceuticals Holding (SHSE:601607) Has Some Way To Go To Become A Multi-Bagger

Aug 09
Shanghai Pharmaceuticals Holding (SHSE:601607) Has Some Way To Go To Become A Multi-Bagger

Shanghai Pharmaceuticals Holding's (SHSE:601607) Dividend Is Being Reduced To CN¥0.41

Jul 18
Shanghai Pharmaceuticals Holding's (SHSE:601607) Dividend Is Being Reduced To CN¥0.41

Shanghai Pharmaceuticals Holding (SHSE:601607) Has A Somewhat Strained Balance Sheet

Jun 25
Shanghai Pharmaceuticals Holding (SHSE:601607) Has A Somewhat Strained Balance Sheet

Shanghai Pharmaceuticals Holding Co., Ltd's (SHSE:601607) Earnings Are Not Doing Enough For Some Investors

May 21
Shanghai Pharmaceuticals Holding Co., Ltd's (SHSE:601607) Earnings Are Not Doing Enough For Some Investors

Earnings Miss: Shanghai Pharmaceuticals Holding Co., Ltd Missed EPS By 30% And Analysts Are Revising Their Forecasts

Apr 01
Earnings Miss: Shanghai Pharmaceuticals Holding Co., Ltd Missed EPS By 30% And Analysts Are Revising Their Forecasts

Returns At Shanghai Pharmaceuticals Holding (SHSE:601607) Appear To Be Weighed Down

Mar 16
Returns At Shanghai Pharmaceuticals Holding (SHSE:601607) Appear To Be Weighed Down

We Think Shanghai Pharmaceuticals Holding (SHSE:601607) Can Stay On Top Of Its Debt

Feb 29
We Think Shanghai Pharmaceuticals Holding (SHSE:601607) Can Stay On Top Of Its Debt

Analyse CEO-vergoeding

Hoe is Bo Shen's beloning veranderd ten opzichte van Shanghai Pharmaceuticals Holding's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Sep 30 2024n/an/a

CN¥4b

Jun 30 2024n/an/a

CN¥4b

Mar 31 2024n/an/a

CN¥4b

Dec 31 2023CN¥6mCN¥1m

CN¥4b

Sep 30 2023n/an/a

CN¥5b

Jun 30 2023n/an/a

CN¥5b

Mar 31 2023n/an/a

CN¥6b

Dec 31 2022CN¥6mCN¥1m

CN¥6b

Sep 30 2022n/an/a

CN¥5b

Jun 30 2022n/an/a

CN¥5b

Mar 31 2022n/an/a

CN¥4b

Dec 31 2021CN¥6mCN¥1m

CN¥5b

Sep 30 2021n/an/a

CN¥5b

Jun 30 2021n/an/a

CN¥6b

Mar 31 2021n/an/a

CN¥6b

Dec 31 2020CN¥5mCN¥1m

CN¥4b

Sep 30 2020n/an/a

CN¥4b

Jun 30 2020n/an/a

CN¥4b

Mar 31 2020n/an/a

CN¥4b

Dec 31 2019CN¥6mCN¥1m

CN¥4b

Sep 30 2019n/an/a

CN¥4b

Jun 30 2019n/an/a

CN¥4b

Mar 31 2019n/an/a

CN¥4b

Dec 31 2018CN¥3mCN¥800k

CN¥4b

Sep 30 2018n/an/a

CN¥4b

Jun 30 2018n/an/a

CN¥4b

Mar 31 2018n/an/a

CN¥4b

Dec 31 2017CN¥2mCN¥800k

CN¥4b

Compensatie versus markt: Bo's total compensation ($USD817.81K) is above average for companies of similar size in the CN market ($USD258.57K).

Compensatie versus inkomsten: Bo's compensation has been consistent with company performance over the past year.

CEO

Bo Shen (51 yo)

14.7yrs

Tenure

CN¥5,800,000

Compensatie

Mr. Bo Shen has been the Chief Financial Officer of Shanghai Pharmaceuticals Holding Co., Ltd. since March 2010 and serves as its Head of the Accounting Department. He serves as President of Shanghai Pharm...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Qiuhua Yang
Executive Chairmanless than a yeargeen gegevensgeen gegevens
Bo Shen
President14.7yrsCN¥5.80m0.0019%
CN¥ 1.3m
Yongzhong Li
VP & Executive Directorno dataCN¥6.19mgeen gegevens
Ming Dong
Executive Director1.4yrsgeen gegevensgeen gegevens
Tao Zhong
VP, Board Secretary & Joint Company Secretary2.3yrsCN¥3.12mgeen gegevens
Dongming Li
Vice President2.7yrsCN¥3.12mgeen gegevens
Shuai Shao
Vice President2.3yrsCN¥2.08mgeen gegevens
Shunjiang Yu
Chief Medical Officerno datageen gegevensgeen gegevens
Pui Kiu Wong
Joint Company Secretaryless than a yeargeen gegevensgeen gegevens
Ying Ke
Director & General Manager of R&D Management Centerno datageen gegevensgeen gegevens
Linqiong Dong
Securities Affairs Representativeno datageen gegevensgeen gegevens

2.3yrs

Gemiddelde duur

52yo

Gemiddelde leeftijd

Ervaren management: 601607's management team is considered experienced (2.3 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Qiuhua Yang
Executive Chairmanless than a yeargeen gegevensgeen gegevens
Bo Shen
President11.4yrsCN¥5.80m0.0019%
CN¥ 1.3m
Yongzhong Li
VP & Executive Director11.4yrsCN¥6.19mgeen gegevens
Ming Dong
Executive Director1.4yrsgeen gegevensgeen gegevens
Wenxue Zhang
Non-Executive Directorless than a yeargeen gegevensgeen gegevens
Manson Fok
Independent Non-Executive Director5.4yrsCN¥300.00kgeen gegevens
Youli Xu
Chief Supervisor8.4yrsgeen gegevensgeen gegevens
Zhaoyang Gu
Independent Non-Executive Director5.4yrsCN¥300.00kgeen gegevens
Weidong Yu
Employee Representative Supervisor1.4yrsgeen gegevensgeen gegevens
Jia Ma
Supervisor1.4yrsgeen gegevensgeen gegevens
Zhong Wang
Independent Non-Executive Director1.4yrsCN¥150.00kgeen gegevens

1.4yrs

Gemiddelde duur

53yo

Gemiddelde leeftijd

Ervaren bestuur: 601607's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.